Cargando…
PD-L1 Expression in Mastocytosis
Programmed death 1 (PD-1), when activated by its ligands PD-L1 and PD-L2, suppresses active immune cells in normal immune regulation to limit autoimmunity and, in tumors, as a mechanism of immune evasion. PD-L1 expression has been described as both a prognostic and predictive marker in many solid an...
Autores principales: | Williams, Margaret, Lidke, Diane S., Hartmann, Karin, George, Tracy I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539475/ https://www.ncbi.nlm.nih.gov/pubmed/31086024 http://dx.doi.org/10.3390/ijms20092362 |
Ejemplares similares
-
Melanoma and Mastocytosis
por: Vojvodic, Aleksandra, et al.
Publicado: (2019) -
Preclinical human models and emerging therapeutics for advanced systemic mastocytosis
por: Arock, Michel, et al.
Publicado: (2018) -
Pediatric Mastocytosis: An Update
por: Giona, Fiorina
Publicado: (2021) -
Cutaneous mastocytosis in childhood
por: Nemat, Katja, et al.
Publicado: (2022) -
Precision Medicine in Systemic Mastocytosis
por: Nicolosi, Maura, et al.
Publicado: (2021)